Abstract:Background Sporadic hepatitis E has become an important public health concern in China. Accurate forecasting of the incidence of hepatitis E is needed to better plan future medical needs. Few mathematical models can be used because hepatitis E morbidity data has both linear and nonlinear patterns. We developed a combined mathematical model using an autoregressive integrated moving average model (ARIMA) and a back propagation neural network (BPNN) to forecast the incidence of hepatitis E. Methods The morbidity data of hepatitis E in Shanghai from 2000 to 2012 were retrieved from the China Information System for Disease Control and Prevention. The ARIMA-BPNN combined model was trained with 144 months of morbidity data from January 2000 to December 2011, validated with 12 months of data January 2012 to December 2012, and then employed to forecast hepatitis E incidence January 2013 to December 2013 in Shanghai. Residual analysis, Root Mean Square Error (RMSE), normalized Bayesian Information Criterion (BIC), and stationary R square methods were used to compare the goodness-of-fit among ARIMA models. The Bayesian regularization back-propagation algorithm was used to train the network. The mean error rate (MER) was used to assess the validity of the combined model. Results A total of 7,489 hepatitis E cases was reported in Shanghai from 2000 to 2012. Goodness-of-fit (stationary R 2 =0.531, BIC= −4.768, Ljung-Box Q statistics=15.59, P =0.482) and parameter estimates were used to determine the best-fitting model as ARIMA (0,1,1)×(0,1,1) 12 . Predicted morbidity values in 2012 from best-fitting ARIMA model and actual morbidity data from 2000 to 2011 were used to further construct the combined model. The MER of the ARIMA model and the ARIMA-BPNN combined model were 0.250 and 0.176, respectively. The forecasted incidence of hepatitis E in 2013 was 0.095 to 0.372 per 100,000 population. There was a seasonal variation with a peak during January-March and a nadir during August-October. Conclusions Time series analysis suggested a seasonal pattern of hepatitis E morbidity in Shanghai, China. An ARIMA-BPNN combined model was used to fit the linear and nonlinear patterns of time series data, and accurately forecast hepatitis E infections.

Forecasting the incidence trend of the reported viral hepatitis A with autoregressive and moving average model

Application of auto regressive integrated moving average model in forecasting incidence of hepatitis E in Hubei Province

Comparison of ARIMA and GM(1,1) models for prediction of hepatitis B in China

ARIMA Model on Prediction of Hepatitis A Attack

The Development of A Combined Mathematical Model to Forecast the Incidence of Hepatitis E in Shanghai, China

The Application of Auto-Regressive Model on HIV/AIDS Infection Rates

Application of Autoregressive Integrated Moving Average Model in Predicting the Reported Notifiable Communicable Diseases in China

[Trend Analysis and Prediction of Viral Hepatitis Incidence in China, 2009-2018].

Application of Time Series Analysis in the Prediction of Incidence Trend of Hepatitis E in Jiangsu Province

ARIMA model of time series for forecasting epidemic situation of AIDS

Application of ARIMA model in prediction of respiratory infectious disease

Application of ARIMA model in predicting monthly incidence of syphilis

Application of Autoregressive Integrated Moving Average Model in Forecasting of the Monthly Incidence Rate in Baoji

Forecasting incidence of hemorrhagic fever with renal syndrome in China using ARIMA model

An Autoregressive Integrated Moving Average Model for Predicting Varicella Outbreaks - China, 2019

Application of an ARFIMA Model to Estimate Hepatitis C Epidemics in Henan, China

The Application of Exponential Smoothing Methods on the Forecast of Hepatitis A in Shanghai

Prediction and Analysis of HIV/AIDS Incidence Based on ARIMA Model in China

[Application of ARIMA Model to Predict Number of Malaria Cases in China].

Research on HIV/AIDS Epidemic Trend Prediction Model Based on ARIMA-LSTM

[The Application of Time Series Analysis in Predicting the Influenza Incidence and Early Warning].